As the adverse health outcomes associated with obesity become increasingly publicized, the provider perspective on the condition has shifted, and providers across all specialties feel progressively more interested in writing off-label prescriptions for diabetes GLP-1s to treat obesity 3
Knowing who actually provides the medical care, which pharmacies fill the prescriptions, what the refund policy says before you pay, and what "compounded" means in the current regulatory environment are no longer optional details
Either way, the formulary should also tell you whether the plan has any prior authorization requirements or quantity limits
Individual Genetic Factors in Cortisol Response and GLP-1 Effectiveness Not all individuals respond identically to semaglutide, and genetic variation in stress-hormone pathways may partly explain these differences
What are the primary challenges associated with the combination of SGLT2is and GLP1-RAs in daily clinical practice